Clinical findings and prevalence of the mutation associated with Primary ciliary dyskinesia in Old English Sheepdogs by Merveille, A.-C. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Clinical findings and prevalence of the mutation associated with Primary ciliary
dyskinesia in Old English Sheepdogs
Merveille, A.-C.; Battaille, G.; Billen, F.; Deleuze, S.; Fredholm, Merete; Thomas, A.; Clercx,
C.; Lequarre, A.-S.
Published in:
Journal of Veterinary Internal Medicine
DOI:
10.1111/jvim.12336
Publication date:
2014
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Merveille, A-C., Battaille, G., Billen, F., Deleuze, S., Fredholm, M., Thomas, A., ... Lequarre, A-S. (2014). Clinical
findings and prevalence of the mutation associated with Primary ciliary dyskinesia in Old English Sheepdogs.
Journal of Veterinary Internal Medicine, 28(3), 771-778. https://doi.org/10.1111/jvim.12336
Download date: 03. Feb. 2020
Clinical Findings and Prevalence of the Mutation Associated with
Primary Ciliary Dyskinesia in Old English Sheepdogs
A.-C. Merveille, G. Battaille, F. Billen, S. Deleuze, M. Fredholm, A. Thomas, C. Clercx, and
A.-S. Lequarre
Background: Primary ciliary dyskinesia (PCD) is generally a recessively inherited disorder characterized by dysfunction
of motile cilia. A mutation in a new causative gene (CCDC39) has been identiﬁed in the Old English Sheepdog (OES).
Objectives: To describe the clinical ﬁndings and the molecular changes of aﬀected dogs and estimate the worldwide
prevalence of the mutation in a large cohort of OES.
Animals: 578 OES, including 28 aﬀected and 550 clinically healthy dogs.
Methods: This retrospective study reviewed the data of OES diagnosed with PCD and OES tested for the mutation.
Clinical data including results of physical examination and further investigations were obtained on 11/28 dogs. CCDC39
expression was assessed by qRT-PCR and Western blot analysis in aﬀected dogs and healthy dogs. DNA was extracted on
561/578 dogs and a genetic test by Taqman technology was developed to genotype the CCDC39 mutation in these dogs.
Results: Clinical ﬁndings were recurrent nasal discharge and cough, pyrexia, leucocytosis, and bronchopneumonia.
Ultrastructural defects were characterized by central microtubular abnormalities and decreased number of inner dynein
arms (IDAs). Molecular analysis revealed a reduced expression of CCDC39 RNA and an absence of CCDC39 protein in
aﬀected dogs compared to healthy dogs. The mutation was more frequent in nonrandomly selected European OES popula-
tion with a higher proportion of carriers (19%) compared to non-European dogs (7%).
Conclusion and Clinical Importance: CCDC39 mutation is dispersed in a worldwide population and is responsible for
PCD in this breed. Genetic testing might enable control of this disease.
Key words: Bronchopneumonia; CCDC39; Ciliary dysfunction; Dog; Genetic.
Primary ciliary dyskinesia (PCD) is a geneticallyheterogeneous disorder characterized by abnor-
mally functioning cilia. The main clinical signs are
recurrent or persistent respiratory infections because of
the lack of eﬀective ciliary motility causing abnormal
mucociliary clearance.1 The dysfunction of the mono-
cilia of the embryonic node might also lead to the ran-
domization of the left-right body asymmetry and
transposition of the thoracic and abdominal organs in
50% of the cases called the Kartagener’s syndrome.2
Male fertility can be impaired because of defects of the
spermatozoa ﬂagella. Disorders such as hydrocephalus
or serous otitis have occasionally been reported.
This condition has been described in human beings
as well as in diﬀerent animals and in particular within
19 breeds of dog.3–8 Dog cases reported often focus on
1 individual from a speciﬁc breed, but sometimes litter-
mates are aﬀected9–11 or diﬀerent cases are segregating
within the same breed.7,12 This genetic disease is usu-
ally inherited in an autosomal recessive mode.7,12
Motile cilia are composed of a microtubule back-
bone, the axonema, consisting of 9 microtubule dou-
blets surrounding a central pair. Inner and outer
dynein arms extend from each outer microtubule dou-
blet and generate the force needed for motility in an
ATP-dependent process. Ciliary dysmotility or immo-
tility is often associated with ultrastructural defects of
the cilia such as total or partial absence of the outer
dynein arms (ODAs), inner dynein arms (IDAs), or
both, defects of radial spokes or nexin links, and gen-
eral axonemal disorganization with microtubular trans-
position.1 There are a large number of genes involved
in the molecular complexity of the cilium13 and until
now only a few have been implicated in the etiology of
PCD mostly through human family based linkage
studies or by candidate gene approach with informa-
tion from genes known to cause speciﬁc ultrastructural
and functional defects in model ciliated species such as
Chlamydomonas14 or mouse.15
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The ﬁrst objective of the study is to detail several
PCD clinical cases segregating within a pedigree of
Old English Sheepdogs (OES). Thanks to this pedigree
a new gene involved in the motility of cilia was discov-
ered: this CCDC39 gene once mutated is responsible
for PCD both in OES and in human.16 The other
objectives of this study are to gain further information
on the molecular consequences of the CCDC39 muta-
tion in the dog and to describe the prevalence of the
mutation in a large cohort of OES.
Materials and Methods
In total, 578 OES were involved in this study, 28 aﬀected and
550 clinically healthy dogs. Among the aﬀected dogs, we
obtained complete clinical data for 5 of them and partial clinical
data or postmortem data for 6 others. The remaining 17 aﬀected
dogs had compatible clinical signs and were identiﬁed based on
interviews with breeders and owners. These dogs were only
included in the pedigree analysis as no DNA was available for
them.
Fifteen healthy dogs were collected from the 2 kennels where
aﬀected dogs were identiﬁed. Dogs were considered as healthy
based on physical examination, if they were older than 7 months,
and if they had no persistent history of signs of respiratory
disease. They were primarily used for the genotyping and the
identiﬁcation of the mutation. For the remaining 535 healthy
dogs, 427 were collected during an exhibition show or directly
sent by breeders or owners and 108 dogs came from a US canine
DNA bank.a DNA samples of American dogs were randomly
collected from various American Kennel Club registered dogs
and were not collected for the study. All these samples have been
used to study the worldwide prevalence of the mutation within
the breed.
Pedigrees of aﬀected dogs and details of their littermates and
parents were obtained when available. Litter analysis of the dogs
was performed to conﬁrm the recessive mode of inheritance.
The 5 aﬀected dogs for which we obtained complete clinical
data were investigated at the small animal clinic of the Univer-
sity of Liege. Blood samples for hematology, biochemistry, and
DNA extraction were obtained from all of them. Thoracic
radiographs (left lateral, right lateral, and dorso-ventral views)
were taken.
Rhinoscopy and bronchoscopy were performed on 3 of these
dogs under anesthesia with the animals breathing spontaneously.
Bronchoscopyb allowed macroscopic evaluation of pharynx, lar-
ynx, and trachea as well as primary and secondary bronchi of
each lung lobe. Bronchoalveolar lavages were cultured for bacte-
ria and examined cytologically. Cell cultures were performed on
nasal and bronchial mucosal biopsies according to previously
described method (ciliogenesis).3 The percentage of transverse
sections of cilia showing abnormalities was determined from each
biopsy on the basis of the examination of 121–249 cilia.
A semen sample obtained from 1 dog by manual ejaculation
was immediately analyzed by light microscopy. Sperm cells were
ﬁxed and stained with a Diﬀ-Quick protocol.
For genotyping, DNA was extracted from 1 mL of total blood
with EDTA. To identify the mutation, SNP genotyping of 5
aﬀected and 15 healthy dogs was performed on canine array. b,16
Brieﬂy, genome-wide association study allowed the identiﬁcation
of one and only 1 region of homozygosity shared by all cases on
chromosome 34 and absent in healthy animals indicating a simple
recessive disease. Statistical analysis demonstrated a highly signif-
icant association (P < .001 genome-wide). This shared segment
was 15 Mb long containing 151 annotated genes. By mining 2
cilioma databases 10 candidate genes were selected as they are
implied in the structure or in the function of the cilium. Sequenc-
ing the coding exons and the intron-exon boundaries of 6 of
them in 1 aﬀected dog, 1 obligated carrier, and 1 healthy dog
allows the identiﬁcation of one single mutation associated with a
loss of function of the CCDC39 gene. A premature stop codon
predicted to truncate 90% of the protein in the aﬀected dogs. No
other disruptive mutation was detected. Furthermore, 10/10 addi-
tional cases were homozygous for the mutation, 10/10 obligated
carriers were heterozygous, whereas the mutation was not found
in 80 healthy animals from 9 other breeds.c
Small pieces of bronchial tissues from aﬀected and healthy
animals were ﬂash-frozen. Total RNA was extracted using com-
mercial RNA puriﬁcation kit.d cDNA was synthesized using
commercial kite and a mixture of random hexamer and oligo
(dT)20 primers according to the instructions of the manufacturer.
Real-time PCR was performed with the 7900HT Real-Time PCR
system.f CCDC39 and internal control genes were detected by
20 ng template cDNA, 19 ABsolute Blue QPCR SYBR Green
Mixg , and 0.1 lM primers in a total volume of 15 lL with a
PCR condition of 15 minutes at 95°C and 40 cycles of 95°C for
15 seconds, and 60°C for 1 minute, followed by a disassociation
curve analysis. Each assay was duplicated and analyzed with
commercial software.h We used 2 amplicons per gene. Data were
normalized using 3 housekeeping genes (HPRT1, ACTB, and
HMBS).
Crude protein extracts of testis, bronchial tissues, and lung
were obtained after disruption and homogenization with a tissue
lyseri and total protein concentrations determined by a colorimet-
ric test.j Fifteen milligrams were diluted in 15 mL ﬁnal volume
(16 SDS gel-loading buﬀer) and loaded on a 5% stacking—10%
resolving Tris-glycine SDS-Polyacrylamide gel. Proteins were sep-
arated by electrophoresis at 120 V–250 mA during 3 hours, visu-
alized by Coomassie blue staining, and electro-transferred
overnight to Hybond P PVDF membranes.k Membranes were
blocked with 5% skim milk in PBS-Tween 20 followed by incu-
bation with polyclonal CCDC39 antibodyl (1 : 200) in a total
volume of 3 mL for 1 hour 30 min. After washing, the speciﬁc
signal was detected by 1 : 1,500 conjugated secondary rabbit
antibodiesm following the instructions of the manufacturer. Mem-
branes were blocked with 5% skim milk in PBS-Tween 20.
A Taqman assay was developed to genotype the CCDC39
mutation, with AGCATTTTAAGATCATTGCTGAGAGAGA
as up PCR primer and TCCCGTATTGAAGTCATTTCATTT
TCCA as down PCR primer, and CTGGGATGAATAAAG
GATGAAAT (Aﬀected), CTGGGACGAATAAAGGATGAA
AT (Wild type), and TCATCCTTTATTCATCCCAG (quencher)
as Taqman probes. Reactions were carried out on 7900HT
instrumente by standard procedures. The percentage of genotyp-
ing as well as the sensitivity and the speciﬁcity of the Taqman
assay were determined by comparison between Taqman genotyp-
ing results and traditional sequencing method on 191 dogs.
Prevalence of the mutation among OES was determined by
including most of the OES samples collected. In order to mini-
mize bias that could lead to an overestimation of the prevalence
of the mutation within European population, dogs used in the
initial genotyping study as well as dogs that were closely related
to the aforementioned were not included in the prevalence study.
The percentages of negative, carrier, and aﬀected dogs were also
calculated. Dogs were recorded as negative (homozygous wild
type) if only cytosine was present at codon 96 in exon 3 of the
CCDC39 gene. Dogs were recorded as carrier (heterozygous) if
both cytosine and thymine were present in that position and sam-
ples were recorded as aﬀected (mutated homozygous) if only thy-
mine was present in that position. We also collected data
regarding country of origin of the dog (breeder localization).
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Results
History and Clinical Findings
Among the 5 initially identiﬁed dogs, 3 (dog 1–3)
were 8-month-old females from the same litter contain-
ing 5 puppies, 1 (dog 4) was an 8-month-old male
from another litter containing 9 puppies also including
2 other aﬀected siblings. The last 1 (dog 5) came from
another litter including 8 puppies and was diagnosed
at 3 years old and 10 months.
All dogs presented few days after their birth recurrent
chronic mucoid to mucopurulent bilateral nasal
discharge, moist productive cough with intermittent
episodes of dyspnea, pyrexia, and anorexia, resolving
only transiently with various treatments (antibiotics,
mucolytics, and nebulization). All dogs were in good
body condition, bright, alert, and responsive.
On presentation, clinical signs included hyperther-
mia, tachypnea, bilateral mucopurulent nasal dis-
charge, and positive tracheal pinch, inducing moist
productive cough. Thoracic auscultation revealed pul-
monary crackles in some dogs. Complete blood count
revealed leukocytosis in all dogs, mainly neutrophilic
and monocytic. Packed cell volume and biochemistry
did not reveal abnormalities in any dog.
Further Investigations
Thoracic radiographs revealed severe bronchointer-
stitial pattern in all aﬀected dogs, associated with
cranial bronchiectasis, alveolar pattern in cranial lung
lobes compatible with bronchopneumonia or lung
consolidation. The cardiac silhouette and the gastric
fundus were in dextroposition on the ventro-dorsal
projection because of situs inversus in 1 dog. Situs
inversus was also identiﬁed on 2 additional aﬀected
dogs.
Direct rhinoscopy revealed hyperemic mucosa, mod-
erate to large amounts of mucopurulent secretions,
and moderate turbinate lysis. During bronchoscopy,
hyperemic mucosa and large amounts of foamy
mucoid secretions were observed along all the upper
and lower airway tracts. Bronchoalveolar lavage ﬂuid
(BALF) analysis was compatible with acute broncho-
pneumonia in 3 cases and BALF culture were positive
for diﬀerent microorganism.
Spermogram conducted on 1 aﬀected male revealed
reduced number of sperm cells (78 9 106, normal
value: >200 9 106) with reduced motility suggesting
oligoasthenospermia. Sperm cells morphologic primary
anomalies were identiﬁed in 55% including narrowed
midpiece (32%) and shortened ﬂagellum (22%)
(Fig 1). 28% of sperm cells were normal whereas 19%
of them had secondary anomalies.
Ultrastructural analysis of the ciliary epithelium of
3 aﬀected dogs revealed large numbers of central
microtubular pair abnormalities (37.4, 37.6, and
22.5%, respectively) compared to control dogs. The
most prominent defect included absent or eccentric
central pairs and occasional central displacement of
A B C
Fig 1. Spermatozoa from an aﬀected dog after Diﬀ-quick protocol staining, showing normal morphology (A), shortened ﬂagella (B),
and narrowed midpiece (C).
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outer doublets. Electron microscopy also revealed
reduction in the mean number of IDAs and high per-
centage of total secondary ciliary abnormalities (72.9,
61.5, and 52.3%, respectively) were also observed. Cil-
iogenesis of 1 dog conﬁrmed central pair anomalies
with eccentric location associated to peripheral dou-
blet transposition into the middle of the axonema
(Fig 2).
Pedigree Analysis
The pedigrees of all aﬀected dogs were analyzed at
least up to 4 generations (Fig 3). Pedigree analysis of
the aﬀected litters indicated a common closest ances-
tor to all parents and all aﬀected dogs. This female
lived in the eighties. This common ancestor won sev-
eral dog shows and was used in Europe for breeding
purpose. Interestingly, both parents of this female are
coming from American line of OES. Litter analysis
showed 28 aﬀected dogs of 66 (42%) total oﬀspring in
13 litters from phenotypically normal parents. Using
Lenz-Hogben correction for bias of ascertainment,
Chi-squared analysis conﬁrmed that the litter analysis
was consistent with a fully penetrant simple autosomal
recessive mode of inheritance (v2 = 0.74, df = 1,
P = .3871).
Molecular Analysis
qRT-PCR analysis revealed a marked reduction in
CCDC39 mRNA within bronchial tissue from aﬀected
dogs compare to control dogs (Fig 4).
Western blot analysis revealed the presence of the
CCDC39 protein in tracheal and bronchial samples
from healthy patient with the expected size of
110.4 kDa, whereas the protein was not present in tra-
cheal and bronchial samples from aﬀected dogs
(Fig 5). This conﬁrms the functional impact of the
mutation with a complete loss of the protein in
aﬀected individuals.
The Taqman assay developed to genotype a large
number of individuals to assess the prevalence of the
mutation in OES population showed a good genotyp-
ing rate (98.45%) and a speciﬁcity and sensitivity of
100% by comparison with traditional sequencing
method.
Prevalence of the Mutation
In total, the 561 OES DNA samples collected origi-
nated from 26 countries; 446 European samples from
22 countries, 110 samples from North America, and 5
samples from other countries. Forty-eight dogs were
not included in the prevalence study because of close
relationship with known aﬀected dogs. Within these
dogs, the proportion of negative dogs (wild type
homozygous), carriers (heterozygous), and aﬀected
dogs (mutated homozygous) were 27% (13/48), 50%
(24/48), and 23% (11/48), respectively. Among the
remaining 513 dogs, the proportion of negative dogs
(wild type homozygous) was 81% (321/398) in the
European population and 93% (107/115) in the other
countries. The proportion of carriers (heterozygous)
were respectively 19% (76/398) and 7% (8/115),
whereas aﬀected dogs (mutated homozygous) were
only identiﬁed in the European OES population (1/
398; <1%). The prevalence of the mutation within
European dogs and non-European dogs was 10 and
3.5%, respectively. Table 1 summarized the number of
wild type homozygous, heterozygous, and mutated
homozygous per country.
Discussion
This study focused on the clinical ﬁndings observed
in OES diagnosed with PCD and on the prevalence
of the causative mutation within a large population
of OES. As expected, the most common clinical signs
were nasal discharge, cough, pyrexia, bronchopneu-
monia, and leukocytosis. A subset of aﬀected dogs
also showed organ laterality defects. The ﬁnal diagno-
sis was achieved through electron microscopy study
and revealed an uncommon phenotype for PCD
patients, characterized by central microtubular abnor-
malities and reduced number of dynein arms. The
molecular analysis reported in this study conﬁrmed
the functional impact of the mutation with a reduced
expression of CCDC39 RNA and the absence of the
A
B
C
Fig 2. Electron microscopy of respiratory cilia from an aﬀected
OES showing the absence of IDAs (1) in all ciliary sections, and
axonemal disorganization with mislocalized peripheral doublet
and displacement of the central pair (2). Magniﬁcation of the
axoneme showing a normal ciliary axonema (A), isolated absence
of IDAs (B), and axonemal disorganization with mislocalized
peripheral doublet and displacement of the central pair (C), sug-
gesting a loss of nexin links and radial spokes.
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protein in aﬀected OES. A main ﬁnding of this study
was a heterogeneous worldwide distribution of the
mutation. Indeed, CCDC39 mutation was more pre-
valent in the European OES population compared to
non-European dogs. However, European dogs were
not randomly selected which might contribute to an
overestimation of the mutation prevalence in this sub-
set of dogs.
PCD is a rare, heterogeneous group of inherited
structural or functional abnormalities of cilia. It occurs
in people with a frequency varying from 1/15,000 to 1/
20,000.1,17,18 There is no sex, racial, or geographic bias
but certain isolated communities might have a higher
prevalence of PCD because of inbreeding. Therefore, it
is not surprising that inbred population such as dog
breeds tend to develop this disease and that PCD has
been reported in more than 19 diﬀerent breeds3–8 and
PCD might even occur more frequently but may not
be correctly diagnosed nor publicly reported.
As genetically heterogeneous PCD might vary in
severity and the organ systems aﬀected according to the
gene implicated. In this pedigree, young onset, constant
rhinosinusitis, and bronchopneumonia with recurrent
acute episodes are typical of PCD as the ineﬀective
ciliary beat results in an impaired mucociliary clear-
ance. All the aﬀected dogs had chronic bilateral nasal
discharge and productive cough that had started few
days after their birth as expected for a hereditary defect.
The early onset is a key feature of this disease, but
aﬀected dogs might be misdiagnosed as cases of aspira-
tion pneumonia, or neonatal respiratory virus infection
and might contribute to an underestimation of the dis-
ease. All dogs were bright with only 1 pyrexic despite
the severe respiratory disease. The hematologic changes
were typical of recurrent airway infection and were
characterized by neutrophilic and monocytic leukocyto-
sis present in 4 of 5 dogs. Thoracic radiographs
revealed severe changes in all cases with typical bron-
chopneumonia lesions aﬀecting the cranial and middle
lung lobes. Bronchoscopy and bronchoalveolar lavage
conﬁrmed bronchopneumonia. Four of 5 aﬀected dogs
Fig 3. Pedigree of aﬀected OES including 13 aﬀected litters and 28 dogs with compatible clinical signs. The pedigree analysis was com-
patible with an autosomal recessive inherited pattern. All aﬀected dogs and all their parents (obligated carriers) were at least linked once
with the same common ancestor bitch (circled). Dogs 1–11 are dogs subsequently conﬁrmed with the homozygous mutation in
CCDC39.
Control 1 Control 2 Dog 7 Dog 8
CCDC39 UP
CCDC39 DOWN
Fig 4. qRT-PCR showing marked reduction in CCDC39 expres-
sion within bronchial tissue from 2 aﬀected dogs compared to 2
control dogs. Two diﬀerent amplicons were used. Fig 5. Western blot showing the presence of the CCDC39 pro-
tein in tracheal, bronchial, and testicular samples from healthy
patient with the expected size of 110.4 kDa and the absence of
the protein in tracheal and bronchial samples (*) from aﬀected
dog. (1) Colored Ladder, (2) Bronchi (Aﬀected), (3) Trachea
(Aﬀected), (4) Testis (Healthy), (5) Bronchi (Healthy), and (6)
Trachea (Healthy).
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had bronchiectasis lesions suggesting continuous pro-
gression of the disease in older dogs. In human, this dis-
ease typically progresses to bronchiectasis during late
childhood or early adulthood and can ultimately cause
chronic respiratory failure.18
The diagnosis of PCD was strengthened by the iden-
tiﬁcation of several cases of situs inversus. Situs inver-
sus totalis, the complete transposition of the thoracic
and abdominal organs, occurs in 50% of PCD cases in
human and occurs in dogs.6,8,19 Situs inversus is
an incidental ﬁnding which causes in the majority of
cases no clinical problems. It is because of dismotility
of cilia on the embryonic node, responsible for visceral
orientation. The result is a visceral orientation deter-
mined by chance, explaining the 50% incidence.2 We
have identiﬁed situs inversus in one-third of these OES
cases (data not shown). Discrepancy between this
result and the expected 50% is most likely because of
the small number of dogs studied.
The results of the semen analysis of 1 aﬀected dog
were typical of PCD with marked reduction in motility
and high percentage of sperm cells morphologic pri-
mary anomalies visible under the light microscope and
aﬀecting sperm ﬂagella. Semen analysis might contrib-
ute to the PCD diagnosis. However, the young onset
of the disease makes its usefulness less obvious in
aﬀected puppies.
The diagnosis of PCD was deﬁnitely conﬁrmed by
defective ciliary ultrastructure under TEM. Those
defects included loss of IDAs, displacement of the cen-
tral pair of microtubules, and some peripheral doublets
displaced centrally suggesting loss of radial spokes and
nexin links. This ultrastructural phenotype is quite
unusual as most of aﬀected human beings and dogs
show a loss of ODAs. It is worth mentioning that the
ultrastructural ﬁndings identiﬁed in aﬀected dogs were
similar to those reported by Randolph et al, in 2 OES
siblings.11
Identifying the genes responsible for PCD is challeng-
ing because of locus and allelic heterogeneity. Cur-
rently, PCD-causing mutations have been identiﬁed in
20 human genes15,20–25 encoding a variety of axonemal
components such as dynein arms, radial spoke, or
dynein regulatory complex. A typical and common
cause of motility defects is a reduction or loss of axone-
mal dyneins which provide the motility to the cilia,
because of a mutation in one of the component of
dynein arms (heavy, intermediate, or light chains). Each
causative gene can be associated with particular ultra-
structural ciliary defects and it is possible that a muta-
tion in the orthologue genes might lead to the same
ultrastructural defect in speciﬁc dog breeds. Therefore,
careful ultrastructural analysis should be a ﬁrst step to
determine the best candidate genes and unravel eventu-
ally the genetic basis of PCD in various dog breeds.
These 20 genes only explain 50% of human PCD
cases, more genes need to be identiﬁed. The dog is an
ideal animal model to identify new causative genes.26
First, it is a spontaneous model of the disease. Second,
the ciliary structure is highly conserved across species
and ﬁnally, purebred dogs represent populations with
little genetic diversity that have arisen over a short per-
iod of time making genetic dissection potentially easier
in dogs than in human. Indeed, this study has shown
that only few dogs are required to identify a locus
signiﬁcantly associated with a recessive monogenic
disease. Some other genetic studies in dogs have lead
to the identiﬁcation of genes responsible for the corre-
sponding monogenic disorder in human26,27 demon-
strating that the dog is a useful model to elucidate
genetic defect, especially monogenic recessive defect.
The functional impact of the mutation has been deﬁ-
nitely conﬁrmed by qRT-PCR and Western blot analy-
sis showing reduced gene expression and absence of
the corresponding protein in aﬀected tissue compared
to healthy individuals.
CCDC39 has been the ﬁrst gene identiﬁed in canine
PCD cases allowing for the development of a genetic
test speciﬁcally designed for OES. This test not only
gave us an idea of the prevalence of the mutation
within the breed but also allowed to start a breeding
program detecting silent carriers and preventing the
birth of aﬀected individuals. A Taqman assay was
developed for this purpose with excellent sensitivity
and speciﬁcity. The mutated allele was found both in
European and in American OES, suggesting a world-
wide distribution. However, the mutation has a higher
frequency among European dogs with 19% heterozy-
Table 1. Number of dogs and percentage of wild type
homozygous, heterozygous, and mutated homozygous
in 561 dogs from 26 diﬀerent countries. Mutated
homozygous were identiﬁed in 5 countries (Belgium,
Denmark, France, Spain, and United Kingdom).
Country
Dogs
Number Healthy Carrier Aﬀected
Austria 5 5
Belgium 67 42 (63) 21 (31) 4 (6)
Canada 2 2
Croatia 4 2 (50) 2 (50)
Czech Republic 7 4 (57) 3 (42)
Denmark 32 19 (59) 11 (34) 2 (6)
Estonia 2 2
Finland 23 18 (78) 5 (22)
France 74 54 (73) 17 (23) 3 (4)
Germany 28 27 (96) 1 (4)
Greece 5 5
Hungary 3 2 (67) 1 (33)
Ireland 10 4 (40) 6 (60)
Italy 11 10 (91) 1 (9)
Japan 2 2
Netherlands 27 22 (81) 5 (19)
Norway 10 10
Poland 12 9 (75) 3 (25)
Portugal 1 1
Russia 5 5
South Africa 3 3
Spain 24 16 (67) 6 (25) 2 (8)
Sweden 14 12 (86) 2 (14)
Switzerland 27 23 (85) 4 (15)
United Kingdom 55 42 (76) 12 (22) 1 (2)
United States 108 100 (93) 8 (7)
Total 561 441 108 12
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gous individuals and a few homozygous only detected
in European countries. The mutation shows a lower
frequency in North America where we have tested
more than 100 individuals with only 7% of heterozy-
gous. The discrepancy between European and Ameri-
can populations might be partly explained by the
nonrandom sampling of European OES. We tried to
correct the nonrandom sampling for European OES
by removing dogs used for the original genotyping
study and dogs that were closely related to these
aﬀected dogs. However, European canine samples
were not collected in a blind fashion as the American
dogs. It is possible that breeders already exposed to
the disease were more interested by a genetic test than
other breeders inducing an overestimation of the
mutation within the European OES population. This
recruitment bias represents one of the limitations of
our study.
The higher frequency in the European population
might also be because of a founder eﬀect as a result of
the intensive use of a few champion dogs in Europe.
Indeed, we were able to show that all aﬀected dogs
and their parents were at least related once to the same
common ancestor. This could illustrate the negative
impact of an intensive use of a champion dog responsi-
ble for spreading a rare variant within a breed. How-
ever, this ﬁnding does not conﬁrm her as a carrier of
the defective gene, but identiﬁes the minimum age of
the defective gene in the population studied. Interest-
ingly, both parents of this female ancestor are coming
from an American line of OES at the same period that
Randolph et al11 described the 2 aﬀected OES with
identical ciliary ultrastructural changes in the United
States, suggesting that this genetic defect might segre-
gate in the breed for at least 30 years. Because of the
higher prevalence of the mutation in Europe, we rec-
ommend the systematic use of genetic test for avoiding
breeding carriers and the birth of aﬀected dog with
associated economic loss for breeders.
In conclusion, this study reports the clinical mani-
festations of PCD on a signiﬁcant number of OES.
CCDC39 is the ﬁrst gene identiﬁed in dogs with PCD,
and this study showed that the mutation of this gene
is frequent in the OES population, especially in
Europe. Furthermore, this study allowed the develop-
ment of a simple genetic test (Taqman assay), which
is currently available for breeding purpose.n The fre-
quencies of the mutation reported in this study will
need to be updated based on worldwide genetic
screening of breeding populations. Finally, we believe
that this approach might be used for PCD in other
breeds to identify underlying genetic defect and should
encourage us to collect data on all dogs aﬀected by
this disease.
Footnotes
a Canine DNA bank from National Human Genome Research
Institute, NIH
b Paediatric bronchoscope, external diameter 4.8 mm, Fujinon
EB-410S videoendoscope, ONYS
c Aﬀymetrix v2.0 Canine array, Santa Clara, CA
d Canine DNA bank for University of Copenhagen
e Promega Maxwell16 Total RNA Puriﬁcation Kit, Madison, WI
f Invitrogen SuperScript III First-Strand Synthesis SuperMix for
qRT-PCR, Merelbeke, Belgium
g Applied Biosystems, Foster City, CA
h Thermo Fisher Scientiﬁc, Aalst, Belgium
i Biogazelle NV qBase plus software, Zwijnaarde, Belgium
j Qiagen Tissue lyser system II, Venlo, Netherlands
k Thermo Fisher Scientiﬁc Pierce BCA Protein Assay kit, Aalst,
Belgium
l GE Healthcare, Diegem, Belgium
m Sigma-Aldrich, Diegem, Belgium
n Antagene. Veterinary genetic tests (http://www.antagene.com),
Limonest, France
Acknowledgments
This work could not have been completed without
the help of veterinarians and Old English Sheepdog
breeders and owners. Special acknowledgment is given
to Elaine Ostrander for providing supplementary
canine DNA samples. This work was supported by
grants from the European Union (FP7-LUPA,
GA-201370) and from «Fonds de la Recherche Scien-
tiﬁque» (FRIA fellowship).
Conflict of Interest Declaration: Anne Thomas works
in Antagene, Animal Genetics Laboratory, Limonest,
France, which provided the genetic test.
References
1. Zariwala MA, Knowles MR, Omran H. Genetic defects in
ciliary structure and function. Annu Rev Physiol 2007;69:423–450.
2. Ibanez-Tallon I, Heintz N, Omran H. To beat or not to
beat: Roles of cilia in development and disease. Hum Mol Genet
2003;12:R27–R35.
3. Clercx C, Peeters D, Beths T, et al. Use of ciliogenesis in
the diagnosis of primary ciliary dyskinesia in a dog. J Am Vet
Med Assoc 2000;217:1681–1685, 1659.
4. Edwards DF, Patton CS, Kennedy JR. Primary ciliary dys-
kinesia in the dog. Probl Vet Med 1992;4:291–319.
5. De Scally M, Lobetti RG, Van Wilpe E. Primary ciliary
dyskinesia in a Staﬀordshire Bull Terrier. J S Afr Vet Assoc
2004;75:150–152.
6. Neil JA, Canapp SO Jr, Cook CR, et al. Kartagener’s syn-
drome in a Dachshund dog. J Am Anim Hosp Assoc 2002;38:
45–49.
7. Watson PJ, Herrtage ME, Sargan D. Primary ciliary dyski-
nesia in Newfoundland dogs. Vet Rec 1998;143:484.
8. Durant AM. What is your diagnosis? Thoracic and abdom-
inal situs inversus totalis. J Am Vet Med Assoc 2008;232:197–
198.
9. Dhein CR, Prieur DJ, Riggs MW, et al. Suspected ciliary
dysfunction in Chinese Shar Pei pups with pneumonia. Am J Vet
Res 1990;51:439–446.
10. Morrison WB, Wilsman NJ, Fox LE, et al. Primary ciliary
dyskinesia in the dog. J Vet Intern Med 1987;1:67–74.
11. Randolph JF, Castleman WL. Immotile cilia syndrome in
two Old English Sheepdog litter-mates. J Small Anim Pract
1984;25:679–686.
Ciliary Dyskinesia in Old English Sheepdogs 777
12. Edwards DF, Kennedy JR, Patton CS, et al. Familial
immotile-cilia syndrome in English Springer Spaniel dogs. Am J
Med Genet 1989;33:290–298.
13. Gherman A, Davis EE, Katsanis N. The ciliary proteome
database: An integrated community resource for the genetic and
functional dissection of cilia. Nat Genet 2006;38:961–962.
14. Pennarun G, Escudier E, Chapelin C, et al. Loss-of-func-
tion mutations in a human gene related to Chlamydomonas rein-
hardtii dynein IC78 result in primary ciliary dyskinesia. Am J
Hum Genet 1999;65:1508–1519.
15. Olbrich H, Schmidts M, Werner C, et al. Recessive
HYDIN mutations cause primary ciliary dyskinesia without ran-
domization of left-right body asymmetry. Am J Hum Genet
2012;91:672–684.
16. Merveille AC, Davis EE, Becker-Heck A, et al. CCDC39
is required for assembly of inner dynein arms and the dynein
regulatory complex and for normal ciliary motility in humans
and dogs. Nat Genet 2011;43:72–78.
17. Escudier E, Duquesnoy P, Papon JF, et al. Ciliary defects
and genetics of primary ciliary dyskinesia. Paediatr Respir Rev
2009;10:51–54.
18. Morillas HN, Zariwala M, Knowles MR. Genetic causes
of bronchiectasis: Primary ciliary dyskinesia. Respiration
2007;74:252–263.
19. Piantedosi D, Cortese L, Meomartino L, et al. Situs inver-
sus totalis associated with subaortic stenosis, restrictive ventricu-
lar septal defect, and tricuspid dysplasia in an adult dog. Can
Vet J 2011;52:1237–1242.
20. Zariwala MA, Omran H, Ferkol TW. The emerging genet-
ics of primary ciliary dyskinesia. Proc Am Thorac Soc
2011;8:430–433.
21. Mitchison HM, Schmidts M, Loges NT, et al. Mutations
in axonemal dynein assembly factor DNAAF3 cause primary cili-
ary dyskinesia. Nat Genet 2012;44:381–389, S381–S382.
22. Horani A, Ferkol TW, Shoseyov D, et al. LRRC6 muta-
tion causes primary ciliary dyskinesia with dynein arm defects.
PLoS ONE 2013;8:e59436.
23. Knowles MR, Leigh MW, Ostrowski LE, et al. Exome
sequencing identiﬁes mutations in CCDC114 as a cause of pri-
mary ciliary dyskinesia. Am J Hum Genet 2013;92:99–106.
24. Panizzi JR, Becker-Heck A, Castleman VH, et al.
CCDC103 mutations cause primary ciliary dyskinesia by disrupt-
ing assembly of ciliary dynein arms. Nat Genet 2012;44:714–719.
25. Horani A, Druley TE, Zariwala MA, et al. Whole-exome
capture and sequencing identiﬁes HEATR2 mutation as a cause of
primary ciliary dyskinesia. Am J Hum Genet 2012;91:685–693.
26. Karlsson EK, Lindblad-Toh K. Leader of the pack: Gene
mapping in dogs and other model organisms. Nat Rev Genet
2008;9:713–725.
27. Grall A, Guaguere E, Planchais S, et al. PNPLA1 muta-
tions cause autosomal recessive congenital ichthyosis in Golden
Retriever dogs and humans. Nat Genet 2012;44:140–147.
778 Merveille et al
